Global Allogenic Stem Cell Therapy Market Key Players Competitive Survey Report 2023
Global Allogenic Stem Cell Therapy Market Key Players Competitive Survey Report 2023
Insights into the Allogenic Stem Cell Therapy Market include supply chain optimization, Allogenic Stem Cell Therapy challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Allogenic Stem Cell Therapy market size in 2022 is 994.9 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 9.85% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Allogenic Stem Cell Therapy market include Athersys Inc. (U.S.), Mesoblast Ltd (Australia), Biorestorative Therapies Inc. (U.S.), Pluristem Inc. (Israel), and Brainstorm Cell Limited. (U.S.). The share of the top 3 players in the Allogenic Stem Cell Therapy market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Allogenic Stem Cell Therapy market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Adult Stem Cells accounted for XX% of Allogenic Stem Cell Therapy market in 2022. Human Embryonic Stem Cells share of XX%.
Musculoskeletal Disorders accounted for XX% of the Allogenic Stem Cell Therapy market in 2022. Wounds accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Allogenic Stem Cell Therapy market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Allogenic Stem Cell Therapy market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Allogenic Stem Cell Therapy market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Allogenic Stem Cell Therapy market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Allogenic Stem Cell Therapy industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
Athersys Inc. (U.S.)
Mesoblast Ltd (Australia)
Biorestorative Therapies Inc. (U.S.)
Pluristem Inc. (Israel)
Brainstorm Cell Limited. (U.S.)
ViaCyte Inc. (U.S.)
Gamida Cell (U.S.)
HOPE BIOSCIENCES (U.S.)
Cellular Biomedicine Group (U.S.)
Smith+Nephew (U.K.)
MEDIPOST (South Korea)
ANTEROGEN.CO, LTD. (South Korea)
NuVasive Inc. (U.S.)
RTI Surgical (U.S.)
AlloSource (U.S.)
JCR Pharmaceuticals Co. Ltd. (Japan)
Takeda Pharmaceutical Company Limited (Japan)
Types list
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Application list
Musculoskeletal Disorders
Wounds
Injuries
Cardiovascular Diseases
Surgeries
Gastrointestinal Diseases
Other
Table of Content
1 Allogenic Stem Cell Therapy Market Introduction and Overview
1.1 Allogenic Stem Cell Therapy Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Allogenic Stem Cell Therapy Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Allogenic Stem Cell Therapy Revenue and Market Share by Type
3 Global Allogenic Stem Cell Therapy Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Allogenic Stem Cell Therapy Revenue Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Allogenic Stem Cell Therapy Market Size (2018-2023)
4.2 Allogenic Stem Cell Therapy Growth Trends Analysis by Regions
4.2.1 Allogenic Stem Cell Therapy Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Allogenic Stem Cell Therapy Historic Revenue Market Size by Regions (2018-2023)
4.2.3 North America Allogenic Stem Cell Therapy Market Size (2018-2023)
4.2.4 Europe Allogenic Stem Cell Therapy Market Size (2018-2023)
4.2.5 Asia-Pacific Allogenic Stem Cell Therapy Market Size (2018-2023)
4.2.6 Latin America Allogenic Stem Cell Therapy Market Size (2018-2023)
4.2.7 Middle East & Africa Allogenic Stem Cell Therapy Market Size (2018-2023)
5 North America
5.1 North America Allogenic Stem Cell Therapy Revenue by Countries
5.1.1 North America Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
5.2 North America Allogenic Stem Cell Therapy Revenue by Types
5.3 North America Allogenic Stem Cell Therapy Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Allogenic Stem Cell Therapy Revenue by Countries
6.1.1 Asia Pacific Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
6.2 Asia Pacific Allogenic Stem Cell Therapy Revenue by Types
6.3 Asia Pacific Allogenic Stem Cell Therapy Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Allogenic Stem Cell Therapy Revenue by Countries
7.1.1 Europe Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
7.2 Europe Allogenic Stem Cell Therapy Revenue by Types
7.3 Europe Allogenic Stem Cell Therapy Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Allogenic Stem Cell Therapy Revenue by Countries
8.1.1 Latin America Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
8.2 Latin America Allogenic Stem Cell Therapy Revenue by Types
8.3 Latin America Allogenic Stem Cell Therapy Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Allogenic Stem Cell Therapy Revenue by Countries
9.1.1 Middle East & Africa Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
9.2 Middle East & Africa Allogenic Stem Cell Therapy Revenue by Types
9.3 Middle East & Africa Allogenic Stem Cell Therapy Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Allogenic Stem Cell Therapy Market Competition, by Players
10.1 Global Allogenic Stem Cell Therapy Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Allogenic Stem Cell Therapy Players Market Share in 2022
10.2.2 Top 6 Allogenic Stem Cell Therapy Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Allogenic Stem Cell Therapy Players Head Office, Business Provided
10.4 Allogenic Stem Cell Therapy Mergers & Acquisitions
10.5 Allogenic Stem Cell Therapy New Entrants and Expansion Plans
11 Players Profiles11.1 Athersys Inc. (U.S.)
11.1.1 Athersys Inc. (U.S.) Company Profile
11.1.2 Allogenic Stem Cell Therapy Product Overview
11.1.3 Athersys Inc. (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.1.4 Athersys Inc. (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 Mesoblast Ltd (Australia)
11.2.1 Mesoblast Ltd (Australia) Company Profile
11.2.2 Allogenic Stem Cell Therapy Product Overview
11.2.3 Mesoblast Ltd (Australia) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.2.4 Mesoblast Ltd (Australia) Business Overview
11.2.5 Recent Developments and Plans
11.3 Biorestorative Therapies Inc. (U.S.)
11.3.1 Biorestorative Therapies Inc. (U.S.) Company Profile
11.3.2 Allogenic Stem Cell Therapy Product Overview
11.3.3 Biorestorative Therapies Inc. (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.3.4 Biorestorative Therapies Inc. (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Pluristem Inc. (Israel)
11.4.1 Pluristem Inc. (Israel) Company Profile
11.4.2 Allogenic Stem Cell Therapy Product Overview
11.4.3 Pluristem Inc. (Israel) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.4.4 Pluristem Inc. (Israel) Business Overview
11.4.5 Recent Developments and Plans
11.5 Brainstorm Cell Limited. (U.S.)
11.5.1 Brainstorm Cell Limited. (U.S.) Company Profile
11.5.2 Allogenic Stem Cell Therapy Product Overview
11.5.3 Brainstorm Cell Limited. (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.5.4 Brainstorm Cell Limited. (U.S.) Business Overview
11.5.5 Recent Developments and Plans
11.6 ViaCyte Inc. (U.S.)
11.6.1 ViaCyte Inc. (U.S.) Company Profile
11.6.2 Allogenic Stem Cell Therapy Product Overview
11.6.3 ViaCyte Inc. (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.6.4 ViaCyte Inc. (U.S.) Business Overview
11.6.5 Recent Developments and Plans
11.7 Gamida Cell (U.S.)
11.7.1 Gamida Cell (U.S.) Company Profile
11.7.2 Allogenic Stem Cell Therapy Product Overview
11.7.3 Gamida Cell (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.7.4 Gamida Cell (U.S.) Business Overview
11.7.5 Recent Developments and Plans
11.8 HOPE BIOSCIENCES (U.S.)
11.8.1 HOPE BIOSCIENCES (U.S.) Company Profile
11.8.2 Allogenic Stem Cell Therapy Product Overview
11.8.3 HOPE BIOSCIENCES (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.8.4 HOPE BIOSCIENCES (U.S.) Business Overview
11.8.5 Recent Developments and Plans
11.9 Cellular Biomedicine Group (U.S.)
11.9.1 Cellular Biomedicine Group (U.S.) Company Profile
11.9.2 Allogenic Stem Cell Therapy Product Overview
11.9.3 Cellular Biomedicine Group (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.9.4 Cellular Biomedicine Group (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Smith+Nephew (U.K.)
11.10.1 Smith+Nephew (U.K.) Company Profile
11.10.2 Allogenic Stem Cell Therapy Product Overview
11.10.3 Smith+Nephew (U.K.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.10.4 Smith+Nephew (U.K.) Business Overview
11.10.5 Recent Developments and Plans
11.11 MEDIPOST (South Korea)
11.11.1 MEDIPOST (South Korea) Company Profile
11.11.2 Allogenic Stem Cell Therapy Product Overview
11.11.3 MEDIPOST (South Korea) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.11.4 MEDIPOST (South Korea) Business Overview
11.11.5 Recent Developments and Plans
11.12 ANTEROGEN.CO, LTD. (South Korea)
11.12.1 ANTEROGEN.CO, LTD. (South Korea) Company Profile
11.12.2 Allogenic Stem Cell Therapy Product Overview
11.12.3 ANTEROGEN.CO, LTD. (South Korea) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.12.4 ANTEROGEN.CO, LTD. (South Korea) Business Overview
11.12.5 Recent Developments and Plans
11.13 NuVasive Inc. (U.S.)
11.13.1 NuVasive Inc. (U.S.) Company Profile
11.13.2 Allogenic Stem Cell Therapy Product Overview
11.13.3 NuVasive Inc. (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.13.4 NuVasive Inc. (U.S.) Business Overview
11.13.5 Recent Developments and Plans
11.14 RTI Surgical (U.S.)
11.14.1 RTI Surgical (U.S.) Company Profile
11.14.2 Allogenic Stem Cell Therapy Product Overview
11.14.3 RTI Surgical (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.14.4 RTI Surgical (U.S.) Business Overview
11.14.5 Recent Developments and Plans
11.15 AlloSource (U.S.)
11.15.1 AlloSource (U.S.) Company Profile
11.15.2 Allogenic Stem Cell Therapy Product Overview
11.15.3 AlloSource (U.S.) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.15.4 AlloSource (U.S.) Business Overview
11.15.5 Recent Developments and Plans
11.16 JCR Pharmaceuticals Co. Ltd. (Japan)
11.16.1 JCR Pharmaceuticals Co. Ltd. (Japan) Company Profile
11.16.2 Allogenic Stem Cell Therapy Product Overview
11.16.3 JCR Pharmaceuticals Co. Ltd. (Japan) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.16.4 JCR Pharmaceuticals Co. Ltd. (Japan) Business Overview
11.16.5 Recent Developments and Plans
11.17 Takeda Pharmaceutical Company Limited (Japan)
11.17.1 Takeda Pharmaceutical Company Limited (Japan) Company Profile
11.17.2 Allogenic Stem Cell Therapy Product Overview
11.17.3 Takeda Pharmaceutical Company Limited (Japan) Allogenic Stem Cell Therapy Market Performance (2018-2023)
11.17.4 Takeda Pharmaceutical Company Limited (Japan) Business Overview
11.17.5 Recent Developments and Plans
12 Global Allogenic Stem Cell Therapy Forecast Market Analysis by Type
12.1 Global Allogenic Stem Cell Therapy Revenue Market Forecast by Type (2023-2029)
13 Global Allogenic Stem Cell Therapy Forecast Market Analysis by Application
13.1 Allogenic Stem Cell Therapy Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Allogenic Stem Cell Therapy Forecast Market Size (2023-2029)
14.2 Allogenic Stem Cell Therapy Growth Trends Forecast Analysis by Regions
14.2.1 Allogenic Stem Cell Therapy Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Allogenic Stem Cell Therapy Forecast Market Size (2023-2029)
14.2.3 Europe Allogenic Stem Cell Therapy Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Allogenic Stem Cell Therapy Forecast Market Size (2023-2029)
14.2.5 Latin America Allogenic Stem Cell Therapy Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Allogenic Stem Cell Therapy Forecast Market Size (2023-2029)
15 Allogenic Stem Cell Therapy Industry Dynamic Analysis
15.1 Allogenic Stem Cell Therapy Market Trends Analysis
15.2 Allogenic Stem Cell Therapy Market Drivers Analysis
15.3 Allogenic Stem Cell Therapy Market Challenges Analysis
15.4 Allogenic Stem Cell Therapy Market Restraints Analysis
Tables & Figures:
List of Tables and Figures
Figure Allogenic Stem Cell Therapy Picture
Table Product Definition of Allogenic Stem Cell Therapy
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Allogenic Stem Cell Therapy Market Size by Type (2018 VS 2023 VS 2029)
Table Global Allogenic Stem Cell Therapy Revenue and Market Size by Type (2018-2023)
Table Global Allogenic Stem Cell Therapy Revenue and Market Share by Type (2018-2023)
Table Global Allogenic Stem Cell Therapy Market Size by Application (2018 VS 2023 VS 2029)
Table Global Allogenic Stem Cell Therapy Revenue Market Size by Application (2018-2023)
Table Global Allogenic Stem Cell Therapy Revenue Market Share by Application (2018-2023)
Figure Global Allogenic Stem Cell Therapy Revenue Market Size (2018-2023)
Table Allogenic Stem Cell Therapy Market Size by Regions: 2018 VS 2023 VS 2029
Table Allogenic Stem Cell Therapy Historic Revenue Market Size by Regions (2018-2023)
Table Allogenic Stem Cell Therapy Historic Revenue Market Share by Regions (2018-2023)
Figure North America Allogenic Stem Cell Therapy Market Size (2018-2023)
Figure Europe Allogenic Stem Cell Therapy Market Size (2018-2023)
Figure Asia-Pacific Allogenic Stem Cell Therapy Market Size (2018-2023)
Figure Latin America Allogenic Stem Cell Therapy Market Size (2018-2023)
Figure Middle East & Africa Allogenic Stem Cell Therapy Market Size (2018-2023)
Table North America Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
Table North America Allogenic Stem Cell Therapy Revenue Market Share by Countries (2018-2023)
Table North America Allogenic Stem Cell Therapy Revenue by Types (2018-2023)
Table North America Allogenic Stem Cell Therapy Revenue Market Share by Types (2018-2023)
Table North America Allogenic Stem Cell Therapy Revenue by Applications (2018-2023)
Table North America Allogenic Stem Cell Therapy Revenue Market Share by Applications (2018-2023)
Figure United States Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Canada Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Table Asia-Pacific Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
Table Asia-Pacific Allogenic Stem Cell Therapy Revenue Market Share by Countries (2018-2023)
Table Asia Pacific Allogenic Stem Cell Therapy Revenue by Types (2018-2023)
Table Asia Pacific Allogenic Stem Cell Therapy Revenue Market Share by Types (2018-2023)
Table Asia Pacific Allogenic Stem Cell Therapy Revenue by Applications (2018-2023)
Table Asia Pacific Allogenic Stem Cell Therapy Revenue Market Share by Applications (2018-2023)
Figure China Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Japan Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Korea Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Southeast Asia Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure India Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Australia Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Table Europe Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
Table Europe Allogenic Stem Cell Therapy Revenue Market Share by Countries (2018-2023)
Table Europe Allogenic Stem Cell Therapy Revenue by Types (2018-2023)
Table Europe Allogenic Stem Cell Therapy Revenue Market Share by Types (2018-2023)
Table Europe Allogenic Stem Cell Therapy Revenue by Applications (2018-2023)
Table Europe Allogenic Stem Cell Therapy Revenue Market Share by Applications (2018-2023)
Figure Germany Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure France Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure UK Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Italy Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Russia Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Spain Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Nordic Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Table Latin America Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
Table Latin America Allogenic Stem Cell Therapy Revenue Market Share by Countries (2018-2023)
Table Latin America Allogenic Stem Cell Therapy Revenue by Types (2018-2023)
Table Latin America Allogenic Stem Cell Therapy Revenue Market Share by Types (2018-2023)
Table Latin America Allogenic Stem Cell Therapy Revenue by Applications (2018-2023)
Table Latin America Allogenic Stem Cell Therapy Revenue Market Share by Applications (2018-2023)
Figure Brazil Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Argentina Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Mexico Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Table Middle East & Africa Allogenic Stem Cell Therapy Revenue by Countries (2018-2023)
Table Middle East & Africa Allogenic Stem Cell Therapy Revenue Market Share by Countries (2018-2023)
Table Middle East & Africa Allogenic Stem Cell Therapy Revenue by Types (2018-2023)
Table Middle East & Africa Allogenic Stem Cell Therapy Revenue Market Share by Types (2018-2023)
Table Middle East & Africa Allogenic Stem Cell Therapy Revenue by Applications (2018-2023)
Table Middle East & Africa Allogenic Stem Cell Therapy Revenue Market Share by Applications (2018-2023)
Figure Egypt Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure South Africa Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure UAE Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Turkey Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Figure Saudi Arabia Allogenic Stem Cell Therapy Revenue and Growth (2018-2023)
Table Global Allogenic Stem Cell Therapy Revenue by Players (2018-2023)
Table Global Allogenic Stem Cell Therapy Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Allogenic Stem Cell Therapy Players Market Concentration Ratio (CR5) (2018-2023)
Table Allogenic Stem Cell Therapy Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Athersys Inc. (U.S.) Profile
Table Product Overview
Table Athersys Inc. (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Athersys Inc. (U.S.) Revenue and Growth Rate
Figure Athersys Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Mesoblast Ltd (Australia) Profile
Table Product Overview
Table Mesoblast Ltd (Australia) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Mesoblast Ltd (Australia) Revenue and Growth Rate
Figure Mesoblast Ltd (Australia) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Biorestorative Therapies Inc. (U.S.) Profile
Table Product Overview
Table Biorestorative Therapies Inc. (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Biorestorative Therapies Inc. (U.S.) Revenue and Growth Rate
Figure Biorestorative Therapies Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Pluristem Inc. (Israel) Profile
Table Product Overview
Table Pluristem Inc. (Israel) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Pluristem Inc. (Israel) Revenue and Growth Rate
Figure Pluristem Inc. (Israel) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Brainstorm Cell Limited. (U.S.) Profile
Table Product Overview
Table Brainstorm Cell Limited. (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Brainstorm Cell Limited. (U.S.) Revenue and Growth Rate
Figure Brainstorm Cell Limited. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table ViaCyte Inc. (U.S.) Profile
Table Product Overview
Table ViaCyte Inc. (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure ViaCyte Inc. (U.S.) Revenue and Growth Rate
Figure ViaCyte Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Gamida Cell (U.S.) Profile
Table Product Overview
Table Gamida Cell (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Gamida Cell (U.S.) Revenue and Growth Rate
Figure Gamida Cell (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table HOPE BIOSCIENCES (U.S.) Profile
Table Product Overview
Table HOPE BIOSCIENCES (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure HOPE BIOSCIENCES (U.S.) Revenue and Growth Rate
Figure HOPE BIOSCIENCES (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Cellular Biomedicine Group (U.S.) Profile
Table Product Overview
Table Cellular Biomedicine Group (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Cellular Biomedicine Group (U.S.) Revenue and Growth Rate
Figure Cellular Biomedicine Group (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Smith+Nephew (U.K.) Profile
Table Product Overview
Table Smith+Nephew (U.K.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Smith+Nephew (U.K.) Revenue and Growth Rate
Figure Smith+Nephew (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table MEDIPOST (South Korea) Profile
Table Product Overview
Table MEDIPOST (South Korea) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure MEDIPOST (South Korea) Revenue and Growth Rate
Figure MEDIPOST (South Korea) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table ANTEROGEN.CO, LTD. (South Korea) Profile
Table Product Overview
Table ANTEROGEN.CO, LTD. (South Korea) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure ANTEROGEN.CO, LTD. (South Korea) Revenue and Growth Rate
Figure ANTEROGEN.CO, LTD. (South Korea) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table NuVasive Inc. (U.S.) Profile
Table Product Overview
Table NuVasive Inc. (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure NuVasive Inc. (U.S.) Revenue and Growth Rate
Figure NuVasive Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table RTI Surgical (U.S.) Profile
Table Product Overview
Table RTI Surgical (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure RTI Surgical (U.S.) Revenue and Growth Rate
Figure RTI Surgical (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table AlloSource (U.S.) Profile
Table Product Overview
Table AlloSource (U.S.) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure AlloSource (U.S.) Revenue and Growth Rate
Figure AlloSource (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table JCR Pharmaceuticals Co. Ltd. (Japan) Profile
Table Product Overview
Table JCR Pharmaceuticals Co. Ltd. (Japan) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure JCR Pharmaceuticals Co. Ltd. (Japan) Revenue and Growth Rate
Figure JCR Pharmaceuticals Co. Ltd. (Japan) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Takeda Pharmaceutical Company Limited (Japan) Profile
Table Product Overview
Table Takeda Pharmaceutical Company Limited (Japan) Allogenic Stem Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Takeda Pharmaceutical Company Limited (Japan) Revenue and Growth Rate
Figure Takeda Pharmaceutical Company Limited (Japan) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Allogenic Stem Cell Therapy Revenue Market Size Forecast by Type (2023-2029)
Table Global Allogenic Stem Cell Therapy Revenue Market Share Forecast by Type (2023-2029)
Table Global Allogenic Stem Cell Therapy Revenue Market Size by Application (2023-2029)
Table Global Allogenic Stem Cell Therapy Revenue Market Share by Application (2023-2029)
Figure Global Allogenic Stem Cell Therapy Revenue Forecast Market Size (2023-2029)
Table Allogenic Stem Cell Therapy Revenue Forecast Market Size by Regions (2023-2029)
Table Allogenic Stem Cell Therapy Revenue Forecast Market Share by Regions (2023-2029)
Figure North America Allogenic Stem Cell Therapy Revenue Forecast Market Size (2023-2029)
Figure Europe Allogenic Stem Cell Therapy Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Allogenic Stem Cell Therapy Revenue Forecast Market Size (2023-2029)
Figure Latin America Allogenic Stem Cell Therapy Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa Allogenic Stem Cell Therapy Revenue Forecast Market Size (2023-2029)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Research Methodology:
Allogenic Stem Cell Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|